Prostaglandins have limited actions on abnormalities of beating induced in cultured heart cells

G A CollinsM J Walker


Prostaglandins are antiarrhythmic in a variety of situations including ischaemic arrhythmias, but the mechanisms involved are not known. In view of this, the protective actions of prostaglandins A2, E2, F1 alpha, F2 beta, and I2 against abnormalities of beating induced in cultured heart cells were investigated. Abnormalities of beating were induced in single cells by variety of agents including ouabain Ca++, K+, dinitrophenol (DNP), and toxic material from the jellyfish Cyanea. Abnormalities were assessed in terms of rate, rate range, subjective arrhythmic behaviour and percent cells beating. The prostaglandins (at 10(-7)-10(-5) M) were added with the arrhythmogenic agent to test for their ability to modify agent-induced beating abnormalities and were compared with lidocaine and quinidine. Prostaglandins alone had minimal direct effects on the cells and only minimally reduced responses to arrhythmogenic agents. The most protective prostaglandins, PGE2 and PGF1 alpha, tended to normalise beating behaviour most noticeably in DNP-treated cells, unlike lidocaine and quinidine which were effective against Ca++-induced changes while worsening those of K+. Thus, a general ability to protect disturbed cardiac cells is not seen with hi...Continue Reading


Jan 1, 1987·Toxicon : Official Journal of the International Society on Toxinology·J W Burnett, G J Calton
Dec 1, 1981·Journal of Pharmacological Methods·G A CollinsM J Walker


Jan 1, 1977·Toxicon : Official Journal of the International Society on Toxinology·M J Walker
Jan 1, 1977·Toxicon : Official Journal of the International Society on Toxinology·M J WalkerD V Godin
Jan 1, 1977·Annual Review of Pharmacology and Toxicology·P Hedqvist
Mar 1, 1978·The Journal of Clinical Investigation·P NeedlemanK C Nicolaou
Nov 1, 1977·Postgraduate Medical Journal·P J Piper
Feb 1, 1978·Circulation Research·M L Ogletree, A M Lefer
Mar 1, 1976·Journal of Molecular and Cellular Cardiology·K Goshima
Feb 1, 1963·Experimental Cell Research·I HARARY, B FARLEY

Related Concepts

Anti-Arrhythmia Agents
Antiarrhythmic [EPC]
Cyanea cnidaria

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.